Psychedelics News October 2020
This is the ongoing blog for psychedelics news in October 2020.
This is the ongoing blog for psychedelics news in October 2020.
One psychedelics company reaches the 3-comma club, another releases the second large app. Psychedelics can help with pain, demoralization (for AIDS survivors), and eating disorders – as preliminary research is showing. And the money keeps flowing towards research with the launch of UC Berkeley’s own psychedelic research lab and Dr Bronner’s continued commitment to the cause.
News about psychedelics hasn’t slowed down a bit during August. Everyone was delighted by the news that MAPS raised the $30 million they need to get MDMA-assisted psychotherapy through Phase III of FDA trials. Within a span of 6 months, they were able to raise this money from both large (from both aisles) and small donors (2700 in total).
This month starts with a feature of Psychedelic Science Review which has ramped up their reporting and translation of scientific papers to understandable blogs. Companies in the psychedelic space continue to release news, but most of it is about acquisitions, not much is about trial outcomes.
As the world is still in partial lockdown, the psychedelics field seems to be evolving quicker than ever before. Much of the news below is related to the plans of companies. Some good news also comes from NGOs as MAPS is fundraising and support for psychedelics is growing in the US and Canda.
May has been a busy month. One that saw more continued investments, a call for an ethics guide, and interesting results from the largest DMT survey to this date.
An overview of psychedelic youtube channels | A focus on psychedelic research (and implementation) and business
In the implementation of psychedelics as medicine, the implemenation is key | Medicalisation will become a reality soon
Psilocybin has been made in yeast in the lab, which could mean even easier (and more accessible) production and distribution of it in the future. A lot of companies keep expanding and MindMed takes the headline a few times. A lot of the research is taking a pause, as COVID-19 ravages through the world.
Find where you can get certification as a psychedelic therapist, practitioner, or coach | Discover who is offering training